Peptide research studies

2026-09-01 ClinicalTrials.gov

Early Semaglutide Re-initiation Post-Sleeve Gastrectomy in Youth Aims to Improve Weight, Cardiometabolic Health

This trial could fundamentally shift the post-operative management of youth undergoing sleeve gastrectomy. **If successful, it would establish a new standard of care for sustained weight loss and cardiometabolic health improvements in th…

2026-10-14 ClinicalTrials.gov

Semaglutide's Long-Term Effects on Body Composition and Running Performance in Well-Trained Athletes to Be Explored

A new randomized, placebo-controlled study will investigate semaglutide's long-term effects on body composition, muscle, and running performance in well-trained athletes.

2026-10-14 ClinicalTrials.gov

Tirzepatide attenuates doxorubicin-induced cardiotoxicity by improving mitochondrial function

This finding suggests a novel therapeutic avenue for preventing or treating **doxorubicin-induced cardiotoxicity**, a major limitation of effective cancer chemotherapy. **Tirzepatide**, already approved for diabetes and weight management…

2026-10-26 ClinicalTrials.gov

Tirzepatide to be evaluated in a 52-week randomized trial for weight management in post-bariatric surgery patients with suboptimal loss.

If successful, **tirzepatide could offer a crucial pharmacological intervention** for patients experiencing suboptimal weight loss or regain after bariatric surgery, a population with limited effective treatment options. This could signi…

2026-10-26 PubMed

IcoSema lowers HbA1c 0.74% and weight 5.15 kg, reducing hypoglycemia vs. basal insulin.

IcoSema, a weekly insulin icodec/semaglutide combo, significantly improved HbA1c by **0.74%** and reduced body weight by **5.15 kg** compared to basal insulin alone in type 2 diabetes.

2026-10-25 EuropePMC

VSL#3 Co-Administration Alters Early Obeticholic Acid Exposure in MASLD Mice

VSL#3 co-administration significantly altered early-phase Obeticholic Acid pharmacokinetics in MASLD mice, suggesting potential drug-probiotic interactions.

2026-10-25 EuropePMC

Semaglutide Remodels Gut Microbiome with Sex-Specific Effects Beyond Appetite Suppression

Semaglutide's impact on the gut microbiome extends beyond appetite suppression, showing sex-specific gut-brain axis implications in preclinical models.

2026-10-25 EuropePMC

Semaglutide Reduced Adiposity, Insulin Resistance in HIV Lipohypertrophy; Durability Explored

Semaglutide previously cut adiposity and insulin resistance in HIV-associated lipohypertrophy. An ongoing Phase 2b RCT investigates if these benefits persist post-discontinuation.

2026-10-25 EuropePMC

PRISMA Review Synthesizes Protein Intake and Resistance Training Guidance for Clinical Populations, Including GLP-1 Users

A PRISMA-guided rapid review synthesizes current evidence on optimal protein intake and resistance training strategies for diverse clinical populations, addressing gaps in general guidelines, particularly for GLP-1 users.

2026-10-25 EuropePMC

Real-world study compares semaglutide and tirzepatide effectiveness for obesity, including prior medication users

Real-world data compared **tirzepatide** and **semaglutide** effectiveness and safety for obesity, including patients with prior anti-obesity medication use.

2026-10-25 EuropePMC

GDF-15/GFRAL axis integrates multiorgan-to-brain stress signals in bariatric surgery, influencing neuropsychiatric outcomes

A review highlights the GDF-15/GFRAL axis as a critical neuroendocrine pathway integrating peripheral stress signals with central metabolic control, influencing neuropsychiatric adaptations post-bariatric surgery.

2026-10-25 EuropePMC

High-Dose IVC and Mistletoe Therapy Explored for Overall Survival in Palliative Breast Cancer

A prospective cohort study investigates the potential of high-dose intravenous vitamin C (IVC) and mistletoe therapy to improve overall survival in breast cancer patients receiving palliative care.

2026-10-25 EuropePMC

Multimodal regenerative peptides show promise for inferior alveolar nerve injury recovery in three case reports

This case series offers a compelling, albeit preliminary, indication that **multimodal regenerative peptide protocols could provide a novel therapeutic avenue for persistent inferior alveolar nerve injury**. For individuals suffering fro…

2026-10-25 PubMed

Letter to the Editor Discusses Oral Calcium Carbonate as Oxytocin Adjunct for Labor Induction Pilot Study

A letter to the editor comments on a randomized controlled pilot study investigating oral calcium carbonate as an adjunct to oxytocin for labor induction, focusing on feasibility and acceptability.

2026-10-25 PubMed

VMT02 PET/CT imaging precisely detects melanoma in mouse models and patients by targeting MC1R

The `VMT02` peptide, a `68Ga`-labeled `α-MSH` analog, enables highly sensitive and specific **melanoma** detection via `PET/CT` imaging in both preclinical models and patients.

2026-10-25 PubMed

Taiwanese Medical Societies Issue Joint Guidelines for MASLD and Obesity Management, Highlighting GLP-1 Agonists

Taiwanese medical societies released joint guidelines for **MASLD** and **obesity** management, recommending a multidisciplinary approach including GLP-1 receptor agonists, resmetirom, and bariatric surgery.

2026-10-25 PubMed

Review highlights Periostin (POSTN) as a promising biomarker and therapeutic target for diabetic kidney disease

Periostin (POSTN) drives renal inflammation and fibrosis in **diabetic kidney disease (DKD)**, emerging as a promising novel biomarker and therapeutic target.

2026-10-25 PubMed

Lower deep-breathing CVR-R predicts early oral semaglutide discontinuation in type 2 diabetes

Lower deep-breathing CVR-R (median **1.93%**) predicted early oral semaglutide discontinuation in T2DM patients, with a cutoff of **2.55%** stratifying persistence.

2026-10-25 PubMed

Cervical Balloon with Oxytocin Significantly Shortens Labor, Boosts Natural Delivery in First-Time Mothers

Combining cervical balloon with **oxytocin** significantly reduced labor time, increased natural delivery rates, and lowered adverse outcomes in full-term primiparas.

2026-10-24 PubMed

Liraglutide Significantly Reduces Systolic Blood Pressure and Improves Renal Function in Type 2 Diabetic Nephropathy

Liraglutide significantly reduced SBP by **5.00 mmHg** and improved multiple renal biomarkers in patients with **Type 2 Diabetic Nephropathy**, according to a meta-analysis of **23 RCTs**.

2026-10-24 PubMed

Single 1 mg Liraglutide Dose Triggers Severe Gastroparesis-like Syndrome in Healthy Female

This case report serves as a critical warning regarding the unsupervised and off-label use of GLP-1 receptor agonists like liraglutide. **Severe gastroparesis-like symptoms can manifest acutely even after a single dose**, highlighting th…

2026-10-24 PubMed

Tirzepatide cuts COPD exacerbations and mortality in T2D patients vs. SGLT2i/DPP-4i.

Tirzepatide significantly reduced COPD exacerbations (HR **0.73** vs SGLT2i, HR **0.72** vs DPP-4i) and all-cause mortality in patients with comorbid **type 2 diabetes** and **COPD**.

2026-10-24 PubMed

Humanin Variants Differentially Regulate BID Fibrilization, Suppressing BAX- and BID-Dependent Membrane Permeabilization

Humanin variants differentially regulate `BID` fibrilization, with specific residues dictating interactions, ultimately suppressing `BAX`- and `tBID`-mediated membrane permeabilization. This clarifies HN's cytoprotective mechanism.

2026-10-23 PubMed

Russian Expert Council identifies Prospekta as strongest adjunctive pharmacotherapy for pediatric ADHD

A Russian Expert Council resolution identified **Prospekta** as having the strongest evidence base for adjunctive pharmacotherapy in pediatric **ADHD**, based on double-blind randomized controlled trials.

2026-10-23 PubMed

Novel compound L22 potently inhibits NLRP3 inflammasome, alleviating ulcerative colitis in animal model

This research provides a highly optimizable lead compound, **L22**, for the treatment of **ulcerative colitis** and potentially other **inflammatory diseases** driven by `NLRP3` activation. **L22**'s high potency, oral bioavailability, a…

2026-10-23 PubMed

Sulfonium-modified echinocandins reverse Cryptococcus resistance by membrane disruption and enhanced cell wall inhibition

This research offers a compelling strategy to combat intrinsically resistant fungal pathogens like **Cryptococcus neoformans**, a critical unmet medical need. **The chemical modification of existing antifungal scaffolds, like echinocandi…

2026-10-23 PubMed

GLP-1 Medication Marketing Raises Concerns Over Body Image and Equitable Access

This commentary is highly relevant for **peptide users, biohackers, and clinicians** alike, as it shifts focus from the pharmacological effects of GLP-1s to their broader societal implications. **Understanding the impact of marketing on …

2026-10-23 PubMed

STAT2 intron retention regulates immune signaling, correlates with PD-L1 immunotherapy response in lung cancer

This research reveals `STAT2` intron retention as a novel interferon regulatory axis that significantly correlates with `PD-L1` checkpoint inhibitor response in **lung cancer**. **This finding could lead to new biomarkers for predicting …

2026-10-23 PubMed

Dual-tracer PET/CT with [68Ga]Ga-DOTATATE and [18F]F-FDG identified unusual gastric metastases in recurrent pancreatic NET, guiding theranostic strategy

This case highlights the critical role of **dual-tracer PET/CT imaging** in managing recurrent **pancreatic NET**, especially when unusual metastatic sites like the stomach are involved. **Clinicians should consider both somatostatin rec…

2026-10-23 PubMed

eIF5-mimic proteins (5MPs) structurally restrict non-AUG start codon usage, reprogramming proteome expression

Understanding the structural basis of **5MP** function provides a novel target for therapeutic intervention in diseases driven by dysregulated translation. **Modulating 5MP activity could offer a precise strategy to correct aberrant prot…

2026-10-23 PubMed

GITR Engagement on ILC2s Drives IL-9 Production, Recruiting Eosinophils to Suppress Tumor Growth

This research defines a novel innate immune pathway where ILC2s drive eosinophil-mediated tumor immunity, offering a potential new target for cancer therapy. **GITR agonism could be a promising therapeutic strategy to enhance anti-tumor …

2026-10-23 PubMed

Warm Needling Moxibustion Outperforms Mild Moxibustion, Reducing KOA Symptoms and Chondrocyte Senescence Markers in Rats

Warm needling moxibustion significantly reduced pain, joint swelling, and improved function in rat knee osteoarthritis, demonstrating superior efficacy over mild moxibustion.

2026-10-23 PubMed

Membrane-MaSIF and PepGraph-Diffusion AI framework designs effective Gram-negative antimicrobial peptides

This mechanism-guided approach to antimicrobial peptide (AMP) design represents a significant leap forward in combating **antibiotic resistance**, particularly against challenging Gram-negative pathogens. **By explicitly modeling peptide…

2026-10-23 ClinicalTrials.gov

MM-141 Initiates Phase 1 Dose-Escalation Trial in Advanced Solid Tumors, Assessing Safety and Pharmacokinetics

Successfully completing a Phase 1 trial for **MM-141** is a critical milestone, as it establishes the foundational safety and pharmacokinetic data necessary for further clinical development. **Identifying a safe and tolerable dose range*…

2022-03-04 ClinicalTrials.gov

Soticlestat as add-on therapy investigated for seizure reduction in Dravet and Lennox-Gastaut Syndromes

For individuals living with **Dravet Syndrome** or **Lennox-Gastaut Syndrome**, and their families, the introduction of an effective add-on therapy like soticlestat could be transformative. Current treatment options often provide insuffi…

2023-01-20 ClinicalTrials.gov

SPAN trial randomizes delivery timing in GDM women to optimize neonatal health 37-39 weeks.

**Optimizing delivery timing in GDM could significantly improve neonatal health outcomes**, reducing complications like respiratory distress, hypoglycemia, and birth trauma. For clinicians, this trial promises to establish an evidence-ba…

2026-10-23 ClinicalTrials.gov

Intranasal Oxytocin Trial Investigates Efficacy in Reducing Alcohol Withdrawal and Long-Term Drinking in Alcohol Dependence

A completed Phase 3 trial assessed intranasal **oxytocin** for reducing alcohol withdrawal symptoms and decreasing drinking in individuals with alcohol dependence.

2026-10-23 ClinicalTrials.gov

Oxytocin nasal spray predicted to enhance social cooperation and reduce threat attention in Social Anxiety Disorder

Oxytocin nasal spray is hypothesized to improve social cooperation, decrease attention to social threats, and increase prosocial reward-seeking in patients with **Social Anxiety Disorder**.

2026-10-23 ClinicalTrials.gov

Intrapartum Oxytocin Administration Investigated for Effects on Neonatal Primitive Reflexes and Breastfeeding

This study aims to assess if intrapartum oxytocin administration impacts neonatal primitive reflexes and 3-month exclusive breastfeeding, exploring potential dose-dependent effects.

2018-10-10 ClinicalTrials.gov

Oxytocin and Mindfulness Training Explored for Impact on Smoking Behavior

If successful, this research could significantly advance strategies for **smoking cessation**. A combined approach using **oxytocin** and mindfulness training might offer a novel, multi-modal intervention for individuals struggling with …

2026-10-23 ClinicalTrials.gov

Intranasal Oxytocin Investigated for Antipsychotic Effects in Schizophrenia Patients

If intranasal oxytocin proves effective in this population, it could represent a significant advance for **schizophrenia** patients who continue to struggle with residual symptoms, particularly those impacting social functioning and qual…

2026-10-23 ClinicalTrials.gov

Study Aims to Investigate Differential Effects of Diabetes Therapies on Kidney Inflammation

**Identifying diabetes therapies that specifically mitigate kidney inflammation could significantly improve patient outcomes**, potentially preventing the progression to kidney failure. If differential effects are found, clinicians could…

2026-10-21 ClinicalTrials.gov

Geroprotective Agents and Topical Peptides Tested for Biological Age Reversal Using Epigenetic Clocks

A human study investigates if systemic geroprotective agents and topical anti-aging peptides can reduce biological age, measured by epigenetic clocks in blood and skin.

2026-10-23 PubMed

Ultrasound-guided pingyangmycin sclerotherapy reduces oral/maxillofacial venous malformation volume by 82% and eliminates discomfort.

Portable ultrasound-guided **pingyangmycin** sclerotherapy achieved an **82%** average volume reduction and eliminated discomfort in **49** patients with deep-seated oral/maxillofacial venous malformations.

2026-10-23 PubMed

Recombinant Lactococcus lactis expressing IFN-γ alleviates viral enteritis in mice via microbial and metabolic modulation

This research introduces a groundbreaking, **antibiotic-free strategy for preventing and treating viral enteritis**, particularly relevant for the animal industry. By combining the probiotic benefits of *Lactococcus lactis* with the pote…

2026-10-23 PubMed

Isotope-labeled full-length β-casein internal standard accurately quantifies milk allergen in complex processed foods

A novel UPLC-MS/MS method utilizing an isotope-labeled full-length **β-casein-I** internal standard achieved 89-116% recovery for milk allergen quantification in processed foods.

2026-10-23 ClinicalTrials.gov

Liraglutide Pretreatment Investigated for Lipid Metabolism, Adipose Inflammation in Bariatric Surgery Candidates

Liraglutide pretreatment is being investigated for its effects on lipid metabolism and adipose tissue inflammation in patients awaiting bariatric surgery.

2026-01-06 ClinicalTrials.gov

Phase 2 Study to Evaluate Ofirnoflast (HT-6184) + Semaglutide Combination for Obese T2DM

A Phase 2 study is evaluating the efficacy and safety of oral ofirnoflast (HT-6184) combined with subcutaneous semaglutide in obese participants with Type 2 Diabetes Mellitus.

2026-10-23 ClinicalTrials.gov

Semaglutide Proposed for Preoperative Use in Bariatric Surgery for BMI ≥60 kg/m² Patients

Semaglutide is proposed as a preoperative intervention for bariatric surgery in patients with BMI ≥60 kg/m², addressing a critical evidence gap in this high-risk cohort.

2026-10-23 PubMed

Engineered Komagataella phaffii boosts EGF production 12.8-fold for cultured meat applications

**This optimized EGF production strategy significantly advances the economic viability and scalability of cultured meat.** By achieving high yields of biologically active EGF, the cost barrier for large-scale cultured meat production can…

2026-10-23 PubMed

Liraglutide significantly reduces lipid accumulation in human orbital fibroblasts from Graves' orbitopathy

Liraglutide significantly cut lipid accumulation in human orbital fibroblasts derived from Graves' orbitopathy patients, showing a favorable biological profile.

2026-10-23 PubMed

Updated Review Outlines Perioperative Management Strategies for Patients on GLP-1 Receptor Agonists to Mitigate Aspiration Risk

This updated review provides crucial, actionable guidance for clinicians, anesthesiologists, and surgeons managing patients on GLP-1RAs. **Adopting these specific medication holding periods and preoperative assessment strategies is essen…

2026-10-23 PubMed

GLP-1 Receptor Agonists Influence Reproductive Health, Contraception, Fertility, and Pregnancy Outcomes

**Clinicians must counsel women of reproductive age on potential GLP-1 RA impacts on contraception and pregnancy.** For those on **tirzepatide**, temporary backup contraception is crucial to prevent unintended pregnancies. While GLP-1 RA…

2026-08-31 ClinicalTrials.gov

Intranasal Octreotide Delivery Explored for Refractory Diabetic Macular Edema Treatment

A study aims to determine the efficacy and safety of intranasal **DDM-octreotide** for **diabetic macular edema** in patients refractory to current anti-VEGF therapies.

2018-06-01 ClinicalTrials.gov

Intranasal Oxytocin's Potential to Boost Psychotherapy for Severe Anxiety and Depression Explored in Upcoming RCT

**If successful, this study could establish intranasal oxytocin as a valuable adjunct to psychotherapy for severe anxiety and depression**, potentially improving treatment response and therapeutic alliance. For clinicians, it would provi…

2026-10-22 ClinicalTrials.gov

Liraglutide's Efficacy and Safety as Adjunct to Insulin Investigated in Type 1 Diabetes

Liraglutide's efficacy and safety as an adjunct to insulin therapy in **Type 1 Diabetes** was the focus of a 52-week, randomized, placebo-controlled trial across multiple continents.

2026-10-22 ClinicalTrials.gov

Liraglutide's Insulinogenic Effects to Be Explored Over Repeated Dosing in Healthy Volunteers

**Understanding how liraglutide's insulin-stimulating effects change over time is crucial for optimizing treatment strategies and predicting long-term efficacy.** If beta-cell responses adapt or desensitize with chronic use, it could inf…

2025-09-01 ClinicalTrials.gov

GLP-1 Receptor Agonists Show Promise for Pre-Total Knee Replacement Obesity Optimization, But Randomized Controlled Trials Are Critically Needed

**For obese individuals considering TKR, this review highlights a critical area of future research, not a current treatment protocol.** While **GLP-1RAs** are effective for weight loss, their specific role in optimizing **TKR** outcomes …

2026-11-08 ClinicalTrials.gov

Thymalfasin combined with chemo-immunotherapy aims to improve 3-year survival in TNBC

For **TNBC** patients, especially those at high risk of residual disease, new strategies to enhance treatment response are critical. **Thymalfasin's** potential to sensitize tumors to existing chemo-immunotherapy could significantly impr…

2026-10-22 EuropePMC

Systematic Review Assesses GLP-1 RAs and Multi-Hormone Modulators for Weight Loss, Blood Pressure

A systematic review and meta-regression aimed to assess GLP-1 receptor agonists and multi-hormone modulators for weight loss and blood pressure lowering in overweight/obesity.

2026-10-21 PubMed

Anti-thymocyte globulin (ATG) triggers TNFα-dependent cell death in T-cell acute lymphoblastic leukemia, with resistance overcome by birinapant.

Anti-thymocyte globulin (ATG) induces `TNFα`-mediated cell death in T-cell acute lymphoblastic leukemia (T-ALL) preclinical models, with resistance overcome by `SMAC mimetic birinapant`.

2026-10-21 PubMed

Engineered human Argonaute 2 (ALTER) achieves superior C-to-U RNA editing with reduced immunogenicity

Engineered human Argonaute 2 (ALTER) delivered **1.9-fold higher** C-to-U RNA editing in HEK293T cells, demonstrating reduced off-target effects and immunogenicity versus Cas13.

2026-10-21 PubMed

Mutant Calreticulin (CALR) drives myeloproliferative neoplasms, targeted by peptide vaccines and antibodies.

Mutant Calreticulin (CALR) is a key driver in BCR:ABL1-negative myeloproliferative neoplasms, offering a specific target for immunotherapies like peptide vaccines and the antibody INCA033989.

2026-10-21 PubMed

Mitomycin C induces p53-dependent proliferation arrest in UC-MSCs without full senescence

This study provides critical insights into the stress response of UC-MSCs, which are widely used in regenerative medicine. The finding that UC-MSCs undergo a p53-dependent proliferation arrest without full senescence, even under signific…

2026-10-21 PubMed

Mild moxibustion at CV8/CV4 alleviates rat dysmenorrhea via TRPV1-NF-κB and oxidative stress.

Mild moxibustion at CV8 and CV4 significantly reduced pain and inflammation in a rat model of primary dysmenorrhea, modulating TRPV1, NF-κB, and oxidative stress pathways.

2023-07-31 ClinicalTrials.gov

Stable Iron Isotope Study to Quantify Iron Absorption and Requirements in Kenyan Pregnant and Lactating Women

A prospective observational study will use stable iron isotopes to quantify absorption and requirements in **250** Kenyan pregnant and lactating women, addressing critical data gaps.

2020-06-05 ClinicalTrials.gov

Online psychoeducation + skills intervention for pregnant women with PTSD enters pilot feasibility testing

If successful, this pilot could pave the way for a highly accessible, scalable **online intervention for pregnant women with PTSD**, potentially overcoming significant barriers to care. Integrating biomarker measurement like **oxytocin**…

2026-10-21 ClinicalTrials.gov

Misoprostol's rectal and sublingual routes compared for reducing C-section blood loss

**Identifying the most effective misoprostol administration route could significantly improve maternal outcomes by reducing blood loss during Caesarean sections.** A clear preference for rectal or sublingual delivery, if demonstrated, wo…

2018-09-01 ClinicalTrials.gov

Early low-dose aspirin therapy in diabetic pregnancies investigated for placental dysfunction prevention

Aspirin therapy in first-trimester diabetic pregnancies is under investigation for preventing placental dysfunction, including preeclampsia, preterm birth, and low birthweight.

2026-10-21 ClinicalTrials.gov

Proposed Study to Evaluate Oxytocin and CBSST for Social Dysfunction in Schizophrenia

**If this study demonstrates efficacy, it could introduce a significantly improved therapeutic strategy for the profound social dysfunction experienced by individuals with schizophrenia.** Current treatments offer only limited benefits, …

2021-08-02 ClinicalTrials.gov

SB-121 (Lactobacillus Reuteri) safety and tolerability in autistic disorder assessed in Phase I crossover trial.

SB-121 (Lactobacillus Reuteri) safety and tolerability in **autistic disorder** subjects (15-45 years) are the primary focus of a 28-day daily-dose Phase I crossover trial.

2022-01-21 ClinicalTrials.gov

Oral misoprostol solution (Cytotec) vs. tablet (Angusta) efficacy for labor induction compared in Phase 4 trial

**Understanding the comparative efficacy of misoprostol formulations is crucial for optimizing labor induction protocols and healthcare resource allocation.** If the significantly cheaper **Cytotec®** solution proves to be non-inferior t…

2026-10-21 PubMed

Amino Acid Sequences Offer High-Capacity, Stable Solution for Next-Generation Data Storage

This conceptual review underscores a transformative shift in how we might approach data storage, moving beyond silicon to biological molecules. **Amino acid sequences offer a path to ultra-dense, highly stable data archives**, potentiall…

2026-10-21 PubMed

Skeletal muscle Miro1 accumulation drives insulin resistance in type 2 diabetes, reversible by exercise

This research identifies skeletal muscle Miro1 as a critical mediator of insulin resistance in **type 2 diabetes**, offering a novel therapeutic target beyond traditional glucose-lowering approaches. **Targeting Miro1, potentially throug…

2026-10-21 PubMed

Baseline Proenkephalin A (PENK) predicts worse kidney outcomes and higher mortality with hydrocortisone in septic shock.

High baseline **Proenkephalin A** (PENK) levels predicted fewer kidney failure-free days and higher mortality in septic shock patients treated with **hydrocortisone**.

2026-10-21 PubMed

Bombyx mori Antimicrobial Peptides (AMPs) rival broad-spectrum antibiotics, inducing bacterial pore formation and lysis

Five novel Antimicrobial Peptides (AMPs) isolated from Bombyx mori larvae demonstrated potent antibacterial activity, inducing bacterial pore formation and cell lysis, rivalling broad-spectrum antibiotics.

2026-10-21 PubMed

Adiponectin-based therapeutics show strong promise for mitigating myocardial ischemia-reperfusion injury via metabolic rebalancing

Adiponectin-based therapeutics consistently reduce infarct size and improve myocardial function in MIRI animal models by stimulating `AMPK`-dependent metabolic rebalancing.

2026-10-21 PubMed

Inulin and calcimimetic combination further suppresses bone turnover and improves bone health in CKD rats

This research suggests a novel strategy to address the persistent **skeletal fragility** in **CKD** patients with **SHPT**, even when **PTH** levels are controlled. **Combining prebiotics like inulin with calcimimetics could offer a more…

2026-10-21 ClinicalTrials.gov

Liraglutide's Effect on Type 2 Diabetes Glycemic Control When Added to Basal Insulin Investigated

A global trial investigated adding **liraglutide** to basal insulin with or without metformin in **Type 2 Diabetes** subjects to assess its effect on glycemic control.

2026-10-21 ClinicalTrials.gov

Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Profile Assessed in Healthy Japanese Volunteers

Understanding a drug's safety, tolerability, and pharmacokinetic profile in specific ethnic groups is paramount for global drug development and personalized medicine. **This foundational data for liraglutide in healthy Japanese males inf…

2023-10-01 ClinicalTrials.gov

Go deeper on one peptide